Simvastatin treatment enhances NMDAR-mediated synaptic transmission by upregulating the surface distribution of the GluN2B subunit. - Wikidata - awgldk - TriplyDB

Simvastatin treatment enhances NMDAR-mediated synaptic transmission by upregulating the surface distribution of the GluN2B subunit.

Simvastatin treatment enhances NMDAR-mediated synaptic transmission by upregulating the surface distribution of the GluN2B subunit.

http://www.wikidata.org/entity/Q34081527

about

Neovascularization and Synaptic Function Regulation with Memantine and Rosuvastatin in a Rat Model of Chronic Cerebral Hypoperfusion.Atorvastatin enhances kainate-induced gamma oscillations in rat hippocampal slices.Dose-Dependent Neuroprotection and Neurotoxicity of Simvastatin through Reduction of Farnesyl Pyrophosphate in Mice Treated with Intracerebroventricular Injection of Aβ 1-42.Systemic or Forebrain Neuron-Specific Deficiency of Geranylgeranyltransferase-1 Impairs Synaptic Plasticity and Reduces Dendritic Spine Density.Simvastatin Enhances Activity and Trafficking of α7 Nicotinic Acetylcholine Receptor in Hippocampal Neurons Through PKC and CaMKII Signaling Pathways.

P2860

Q47881880-BCA7E0BA-E13D-41DD-9679-1FB31F39FECA Q48659946-DE404E53-A0C6-45E0-976E-59CEBAFB409E Q49012445-CA151E9C-D524-4E66-940E-A78BEAF06B9F Q50184556-5E60F5AD-B51A-4B77-B169-8A2DEB051FA7 Q54980049-EABEC911-97A8-491E-9A8D-47DEF425BF92

P2860

Simvastatin treatment enhances NMDAR-mediated synaptic transmission by upregulating the surface distribution of the GluN2B subunit.

http://www.wikidata.org/entity/Q34081527

description

2014 nî lūn-bûn

@nan

2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Simvastatin treatment enhances ...... ibution of the GluN2B subunit.

@ast

Simvastatin treatment enhances ...... ibution of the GluN2B subunit.

@en

Simvastatin treatment enhances ...... ibution of the GluN2B subunit.

@nl

type

label

Simvastatin treatment enhances ...... ibution of the GluN2B subunit.

@ast

Simvastatin treatment enhances ...... ibution of the GluN2B subunit.

@en

Simvastatin treatment enhances ...... ibution of the GluN2B subunit.

@nl

prefLabel

Simvastatin treatment enhances ...... ibution of the GluN2B subunit.

@ast

Simvastatin treatment enhances ...... ibution of the GluN2B subunit.

@en

Simvastatin treatment enhances ...... ibution of the GluN2B subunit.

@nl

P1433

Q34081527-9164C240-B110-4BE1-BDBF-D34F0A73347C

P1476

Q34081527-118F4D4E-B1CB-4929-A64C-02D7C396B1E0

P2093

Q34081527-833F146E-D183-465A-8A1F-716F6643C618

Q34081527-8D6C188A-8457-4C9C-B52A-3F859593EDA2

Q34081527-C4132BC5-048D-4096-B30E-CE692845A4C1

Q34081527-DC9B3FF5-0EC7-441A-AF3C-3022ECBF1E3C

Q34081527-DCEDA412-3C40-46A4-84D1-3B992049AFD2

P2860

Q34081527-07A853DE-9B52-4514-A3A8-997BB6338732

Q34081527-07E09E03-09D3-4DCE-A96D-9D66F10F4C4D

Q34081527-14CE9429-B75C-4563-BDBE-6358E168FE83

Q34081527-16195C66-DEA6-436B-9C8C-D5F7D1B9A4F3

Q34081527-19DC45A9-12A5-47F9-800E-F4982B370559

Q34081527-281B1DF8-9A43-4047-8477-E5E0A8BC9138

Q34081527-2C707AD6-97B7-44C8-8F0A-2918D39AB8FF

Q34081527-2CC58198-E4A2-4337-8D71-ABE1DC97C176

Q34081527-38E0BD6C-4C30-49AF-A9B2-2A21477BC57A

Q34081527-3A2AF05B-E580-4506-9926-9F8CBB2E0AAB

P2888

Q34081527-12FBFD99-6992-4DA8-A0EB-6CC9E00E7526

P304

Q34081527-F21BE8FE-56AD-4976-A4CB-816C18DEF7F9

P31

Q34081527-7AFCC1D2-BA63-46A8-899D-97EADF50A9DC

P356

Q34081527-F795B1F0-E39D-4C6D-B154-28247270C356

P433

Q34081527-1B31B10F-9584-4811-ACC9-E0AC666102EC

P478

Q34081527-0AEFF222-9389-463B-A91C-71FE4B3FCB78

P50

Q34081527-481BC8FB-66C0-45DE-8E92-3F9EB31B66E5

Q34081527-BE18F8C6-742E-4EAB-AD16-3B1DBAC48FB1

P577

Q34081527-BE6F0D8D-ADE1-4ED1-843D-57823787E1CA

P5875

Q34081527-184060CD-E8FF-461E-894C-200313B2DFD0

P6179

Q34081527-DBEB2648-DC61-4447-9FD6-93C467A3E5F1

P698

Q34081527-B313E499-AEA2-44A9-A117-8E850C0170F0

P932

Q34081527-9481A120-D0DD-4704-890B-F69EFBDE1516

P356

S10571-014-0051-Z

P1433

Cellular and Molecular Neurobiology

P1476

Simvastatin treatment enhances ...... ribution of the GluN2B subunit

@en

P2093

David A Hottman

http://www.w3.org/2001/XMLSchema#string

Li-Lian Yuan

http://www.w3.org/2001/XMLSchema#string

Lori L McMahon

http://www.w3.org/2001/XMLSchema#string

Marc-Alexander L T Parent

http://www.w3.org/2001/XMLSchema#string

Wei Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

Genetic enhancement of learning and memory in mice

Simvastatin inhibits the activation of p21ras and prevents the loss of dopaminergic neurons in a mouse model of Parkinson's disease

Cortico-striatal synaptic defects and OCD-like behaviours in Sapap3-mutant mice.

Isoprenoid biosynthesis in hereditary periodic fever syndromes and inflammation

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

Regulation of NMDA receptor trafficking by amyloid-beta

NMDA receptor GluN2B (GluR epsilon 2/NR2B) subunit is crucial for channel function, postsynaptic macromolecular organization, and actin cytoskeleton at hippocampal CA3 synapses

The HMG-CoA reductase inhibitor lovastatin reverses the learning and attention deficits in a mouse model of neurofibromatosis type 1

Mechanism for the learning deficits in a mouse model of neurofibromatosis type 1

A receptor-mediated pathway for cholesterol homeostasis

P2888

s10571-014-0051-z

P304

693-705

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10571-014-0051-Z

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

34

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

261256795

http://www.w3.org/2001/XMLSchema#string

P6179

1018452924

http://www.w3.org/2001/XMLSchema#string

P698

24687455

http://www.w3.org/2001/XMLSchema#string

P932

4142643

http://www.w3.org/2001/XMLSchema#string